Given the potential involvement of ERα in mammary gland development, as well as in breast cancer initiation and progression, we investigated for the first time, genome-wide ERα binding events by chromatin immunoprecipitation followed by high-throughput sequencing in mouse mammary gland under in vivo conditions of acute treatment with estradiol. Here, ESR1 is linked to breast cancer.